Met Life Investment Management, LLC Aptinyx Inc. Transaction History

Met Life Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$3.99 - $19.33 $39,860 - $193,106	-9,990 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$16.15 - $28.93 $161,338 - $289,010	9,990 New	9,990 $165,000
Q4 2018 Mar 22, 2023	SELL	$16.15 - $28.93 $91,279 - $163,512	-5,652 Reduced 36.13%	9,990 $165,000
Q4 2018 Feb 14, 2019	SELL	$16.15 - $28.93 $91,279 - $163,512	-5,652 Reduced 36.13%	9,990 $165,000
Q3 2018 Jul 13, 2023	BUY	$20.21 - $31.85 $201,897 - $318,181	9,990 New	9,990 $289,000
Q3 2018 Mar 22, 2023	BUY	$20.21 - $31.85 $316,124 - $498,197	15,642 New	15,642 $452,000
Q3 2018 Nov 14, 2018	BUY	$20.21 - $31.85 $316,124 - $498,197	15,642 New	15,642 $453,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.